Sosman JA - Search Results

1

Innovations and challenges in melanoma: summary statement from the first Cambridge conference.

Atkins MB, Elder DE, Essner R, Flaherty KT, Gajewski TF, Haluska FG, Hwu P, Keilholz U, Kirkwood JM, Mier JW, Ross MI, Slingluff CL, Sondak VK, Sosman JA, Weinstock MA, King L. Atkins MB, et al. Among authors: sosman ja. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2291s-2296s. doi: 10.1158/1078-0432.CCR-05-2560. Clin Cancer Res. 2006. PMID: 16609047

2

Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma.

Atkins MB, O'Boyle KR, Sosman JA, Weiss GR, Margolin KA, Ernest ML, Kappler K, Mier JW, Sparano JA, Fisher RI, et al. Atkins MB, et al. Among authors: sosman ja. J Clin Oncol. 1994 Aug;12(8):1553-60. doi: 10.1200/JCO.1994.12.8.1553. J Clin Oncol. 1994. PMID: 8040667 Clinical Trial.

3

Phase IB clinical trial of anti-CD3 followed by high-dose bolus interleukin-2 in patients with metastatic melanoma and advanced renal cell carcinoma: clinical and immunologic effects.

Sosman JA, Weiss GR, Margolin KA, Aronson FR, Sznol M, Atkins MB, O'Boyle K, Fisher RI, Boldt DH, Doroshow J, et al. Sosman JA, et al. J Clin Oncol. 1993 Aug;11(8):1496-505. doi: 10.1200/JCO.1993.11.8.1496. J Clin Oncol. 1993. PMID: 8336188 Clinical Trial.

4

Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group Study.

Dutcher JP, Fisher RI, Weiss G, Aronson F, Margolin K, Louie A, Mier J, Caliendo G, Sosman JA, Eckardt JR, Ernest ML, Doroshow J, Atkins M. Dutcher JP, et al. Among authors: sosman ja. Cancer J Sci Am. 1997 May-Jun;3(3):157-62. Cancer J Sci Am. 1997. PMID: 9161781 Clinical Trial.

5

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study.

Margolin KA, Liu PY, Flaherty LE, Sosman JA, Walker MJ, Smith JW 3rd, Fletcher WS, Weiss GR, Unger JM, Sondak VK. Margolin KA, et al. Among authors: sosman ja. J Clin Oncol. 1998 Feb;16(2):664-9. doi: 10.1200/JCO.1998.16.2.664. J Clin Oncol. 1998. PMID: 9469356 Clinical Trial.

6

Concurrent phase I trials of intravenous interleukin 6 in solid tumor patients: reversible dose-limiting neurological toxicity.

Sosman JA, Aronson FR, Sznol M, Atkins MB, Dutcher JP, Weiss GR, Isaacs RE, Margolin KA, Fisher RI, Ernest ML, Mier J, Oleksowicz L, Eckhardt JR, Levitt D, Doroshow JH. Sosman JA, et al. Clin Cancer Res. 1997 Jan;3(1):39-46. Clin Cancer Res. 1997. PMID: 9815535 Clinical Trial.

7

Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma.

Margolin K, Atkins M, Sparano J, Sosman J, Weiss G, Lotze M, Doroshow J, Mier J, O'Boyle K, Fisher R, Campbell E, Rubin J, Federighi D, Bursten S. Margolin K, et al. Clin Cancer Res. 1997 Apr;3(4):565-72. Clin Cancer Res. 1997. PMID: 9815721 Clinical Trial.

8

Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial.

Margolin KA, Liu PY, Unger JM, Fletcher WS, Flaherty LE, Urba WJ, Hersh EM, Hutchins LE, Sosman JA, Smith JW, Weiss GR, Sondak VK. Margolin KA, et al. Among authors: sosman ja. J Cancer Res Clin Oncol. 1999;125(5):292-6. doi: 10.1007/s004320050276. J Cancer Res Clin Oncol. 1999. PMID: 10359134 Free article. Clinical Trial.

9

Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.

Dutcher JP, Logan T, Gordon M, Sosman J, Weiss G, Margolin K, Plasse T, Mier J, Lotze M, Clark J, Atkins M. Dutcher JP, et al. Clin Cancer Res. 2000 Sep;6(9):3442-50. Clin Cancer Res. 2000. PMID: 10999727 Clinical Trial.

10

A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma.

Atkins MB, Redman B, Mier J, Gollob J, Weber J, Sosman J, MacPherson BL, Plasse T. Atkins MB, et al. Clin Cancer Res. 2001 Mar;7(3):486-92. Clin Cancer Res. 2001. PMID: 11297238 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page